Background/Aims Clear guidelines for managing patients on antiplatelet (AP) or anticoagulant (AC) therapy undergoing ...

Purpose To assess the prevalence of anxiety and depression among individuals diagnosed with glaucoma, using standardised psychometric instruments, to define factors associated with these psychological ...

All ophthalmologists will encounter patients presenting with an inherited retinal disease (IRD). Our clinical approach to IRDs has evolved over the last decade due to (1) improved and more accessible ...

This is an overview of systematic reviews to evaluate the visual outcomes of different presbyopia correcting intraocular lens (IOL), spectacle independence (SI), adverse visual effects and ...

Background/aims Macrophage-like cells (MLCs) contribute to retinal immune homeostasis and support neuronal function. This study aimed to investigate the relationship between MLCs and ganglion cell ...

Background/aims Sebaceous carcinoma (SC) is a rare cancer with periocular predilection. Studies focused on patterns and timing of nodal metastasis are scarce. Our aim is to report patterns of regional ...

Introduction Glaucoma is a lifelong condition often requiring surgical intervention. To allow us to inform patients’ expectations of surgery effectively, it is important to understand patients’ ...

Background/aims To assess adherence to spectacle wear among children attending public and private schools in urban and rural locations in Kerala, Maharashtra, Madhya Pradesh, Tamil Nadu and West ...

Background To assess the prevalence and causes of vision impairment in North Africa and the Middle East (NAME) from 1990 to 2015 and to forecast projections for 2020. Methods Based on a systematic ...

AIMS To describe the effects of sex and age on eyeball, eyelid, and eyebrow position. METHODS A cross sectional cohort study was performed in which both eyes of 320 normal subjects aged between 10 and ...

Impact of retinal thickness fluctuations with ranibizumab versus aflibercept in neovascular age-related macular degeneration (SALT): 12-month results from a multicentre, randomised, phase IV trial ...